<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00935441</url>
  </required_header>
  <id_info>
    <org_study_id>4127-B</org_study_id>
    <nct_id>NCT00935441</nct_id>
  </id_info>
  <brief_title>Effect of Case-Management Using Home Monitoring on Diabetes and Blood Pressure Outcomes</brief_title>
  <official_title>Effect of Nurse-Based, Protocol-Driven, Case-Management Utilizing Home Telemonitoring and Home HbA1c Measurement on Diabetes and Blood Pressure Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minneapolis Veterans Affairs Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minneapolis Veterans Affairs Medical Center</source>
  <brief_summary>
    <textblock>
      This is a randomized trial designed to determine if adoption of the chronic care model in&#xD;
      conjunction with nurse case management, home telemonitoring, and home HbA1c monitoring can&#xD;
      improve glycemic control compared to patients receiving usual case management. We hypothesize&#xD;
      that nurse case management, with home telemonitoring of blood sugars and home HbA1c&#xD;
      measurement will result in additional improvements in glycemic control compared to isolated&#xD;
      nurse case management. Specifically, the telemonitoring group will have an HbA1c 0.5% lower&#xD;
      compared to usual nurse case management. Secondary aims include an additional 5 mmHg&#xD;
      improvement in systolic blood pressure (among patients with hypertension at the time of&#xD;
      enrollment), improved patient satisfaction with treatment, improved medication adherence,&#xD;
      reduced incidence of hypoglycemia, and reduced case manager time in the telemonitoring/home&#xD;
      HbA1c group compared with usual caes management. The study will enroll 460 diabetic patients&#xD;
      with HbA1c values greater than 8.5%, age 75 years or younger, who have a active land-line for&#xD;
      telephone communication. Patients will be enrolled and actively case managed for 9 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycemic control (HbA1c)</measure>
    <time_frame>9 months after enrollment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure control in patients with elevated blood pressure at baseline</measure>
    <time_frame>9 months after enrollment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">460</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Telemonitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Case management with home telemonitoring for blood sugar and blood pressure plus home HbA1c measurement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual case management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Case management</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>case management with telemonitoring</intervention_name>
    <description>telephone contact with a case manager, home telemonitoring equipment for blood sugar and blood pressure, home HbA1c measurement</description>
    <arm_group_label>Telemonitoring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>usual case management</intervention_name>
    <description>telephone contact with a case manager</description>
    <arm_group_label>Usual case management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Enrolled at Minneapolis VAMC,&#xD;
&#xD;
          -  Type 1 or 2 Diabetes,&#xD;
&#xD;
          -  HbA1c &gt;8.5%,&#xD;
&#xD;
          -  active land-line telephone connection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &gt;75 years,&#xD;
&#xD;
          -  primary care provider unwilling to have patient enrolled,&#xD;
&#xD;
          -  active dialysis,&#xD;
&#xD;
          -  resident of assisted living facility,&#xD;
&#xD;
          -  research participant in previous diabetes case management study,&#xD;
&#xD;
          -  life expectancy &lt;1 year,&#xD;
&#xD;
          -  severe mental health condition,&#xD;
&#xD;
          -  active substance abuse,&#xD;
&#xD;
          -  pregnant or planning on becoming pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Minneapolis VAMC</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55417</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <study_first_submitted>July 8, 2009</study_first_submitted>
  <study_first_submitted_qc>July 8, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2009</study_first_posted>
  <last_update_submitted>September 14, 2011</last_update_submitted>
  <last_update_submitted_qc>September 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minneapolis Veterans Affairs Medical Center</investigator_affiliation>
    <investigator_full_name>Nacide Ercan-Fang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Diabetes mellitus</keyword>
  <keyword>chronic care</keyword>
  <keyword>case management</keyword>
  <keyword>telemedicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

